Table 4.
Proportion of participants that would still take a drug if testing showed it contained the additional presence of the drugs listed
| Drug | Would take | Would not take | Do not know |
|---|---|---|---|
| Ecstasy/MDMA % (n = 422) |
69.7 (294) | 17.8 (75) | 12.6 (53) |
| Amphetamine % (n = 398) |
32.9 (131) | 46.7 (186) | 20.4 (81) |
| Methamphetamine % (n = 390) |
14.9 (58) | 65.1 (254) | 20.0 (78) |
| Ketamine % (n = 398) |
20.9 (83) | 57.5 (229) | 21.6 (86) |
| DXM % (n = 388) |
7.0 (27) | 59.3 (230) | 33.8 (131) |
| 2C-B/CA % (n = 390) |
7.9 (31) | 57.4 (224) | 34.6 (135) |
| DOB % (n = 386) |
3.1 (12) | 59.1 (228) | 37.8 (146) |
| DOI % (n = 384) |
3.1 (12) | 58.6 (225) | 38.3 (147) |
| Methylone % (n = 381) |
3.1 (12) | 59.3 (226) | 37.5 (143) |
| Butylone % (n = 380) |
1.8 (7) | 59.2 (225) | 38.9 (148) |
| Naphyrone % (n = 377) |
1.9 (7) | 59.4 (224) | 38.7 (146) |
| Opiates % (n = 383) |
15.7 (60) | 53.3 (204) | 31.1 (119) |
| PMA/PMMA % (n = 365) |
3.8 (14) | 58.4 (213) | 37.8 (138) |
| Other % (n = 315) |
2.5 (8) | 59.4 (187) | 38.1 (120) |
| No reaction/benign substances % (n = 328) |
6.4 (21) | 57.6 (189) | 36.0 (118) |
DXM dextromethorphan, 2C-B/CA 2,5-dimethoxy-4-bromophenethylamine, DOB dimethoxybromoamphetamine, DOI 2,5-dimethoxy-4-iodoamphetamine